// App-Quantinova.ai

494 : Evaluation of soluble FLT3 ligand as a marker of bone marrow stress and recovery

Researchers

Presenter

  • Christine Sastri

Principal Investigators

  • Mercedesz Balazs

  • Priya Koppikar

  • James R. Lipford

  • Angela Coxon

  • Tara L. Arvedson

Medical Centers

  • Amgen Inc, Thousand Oaks, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Fms related tyrosine kinase 3

  • Fms related tyrosine kinase 3 Ligand

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A